A study utilizing a mouse model with inducible expression of BCR-ABL1 in hematopoietic stem and progenitor cells, mirroring CML progression in humans, revealed elevated MYC expression during progression of CML to BP. The gene discussed is MYC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.